유방 MRI 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 영상 기술/조영제 사용별, 병상별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Breast MRI Market Summary

The global breast MRI market size was valued at USD 2.30 billion in 2024 and is projected to reach USD 5.28 billion by 2033, growing at a CAGR of 9.70% from 2025 to 2033. The demand for breast MRI is rising owing to the advancements in MRI technology and the growing burden of breast cancer.

In addition, growing awareness and screening initiatives for breast cancer are anticipated to drive market growth in the coming years. The rising global burden of breast cancer is a significant factor driving the growth of the breast MRI market. Breast magnetic resonance imaging is widely used to detect additional cancerous areas within the breast and serves as a critical screening tool for individuals at high risk of developing breast cancer. According to data released by the World Health Organization in February 2025, approximately 1 in 20 women worldwide will be diagnosed with breast cancer during their lifetime. If current trends persist, the number of new breast cancer cases is projected to reach 3.2 million annually by 2050, accompanied by 1.1 million deaths related to the disease each year. In 2022 alone, an estimated 2.3 million new breast cancer cases and 670,000 related deaths were reported globally. This increasing prevalence of breast cancer is expected to significantly boost the demand for breast MRI throughout the forecast period.

In addition to the global rise in breast cancer cases, several key regions-including Asia, Europe, North America, and Latin America-are experiencing significant prevalence of the disease. The graph below highlights the growing regional burden of breast cancer, illustrating the predicted incidence rates by 2030.

Global Breast MRI Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast MRI market report based on product, imaging technique/contrast use, condition, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Systems
  • By MRI System Type
  • Closed MRI Systems
  • Open MRI Systems
  • By Field Strength
  • 1.5 Tesla (1.5T)
  • 3 Tesla (3T)
  • 7 Tesla (7T)
  • By Dimensional Modality
  • 3D Breast MRI
  • 4D Breast MRI
• Coils
  • By Coil Configuration
  • Unilateral Breast Coils
  • Bilateral Breast Coils
  • By Channel Count
  • 8-Channel Breast Coils
  • 16-Channel (or Higher) Breast Coils
  • By Functionality
  • Diagnostic-Only Coils
  • Biopsy-Compatible Breast Coils
• Software
• Imaging Technique / Contrast Use Outlook (Revenue, USD Million, 2021 - 2033)
• Contrast-Enhanced MRI (CE-MRI)
• Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
• Condition Outlook (Revenue, USD Million, 2021 - 2033)
• Malignant
• Benign
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Diagnostic Imaging Centers
• Breast Care Centers
• Academic & Research Institutes
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Imaging Technique / Contrast Use
  • 1.1.3. Condition
  • 1.1.4. End-use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast MRI Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing burden of breast cancer
    • 3.2.1.2. Advancements in MRI technology
    • 3.2.1.3. Introduction of innovative and advanced products
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of breast MRI
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Growing awareness of early detection
    • 3.2.3.3. Growth potential in emerging economies in breast MRI market
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Shortage of trained radiologists
• 3.3. Breast MRI Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Breast MRI Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Breast MRI Market Product Movement Analysis
• 4.3. Global Breast MRI Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Systems
  • 4.4.1. Systems market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.1. By MRI System Type
      • 4.4.1.1.1. Closed MRI Systems
        • 4.4.1.1.1.1. Closed MRI systems market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.1.2. Open MRI Systems
        • 4.4.1.1.2.1. Open MRI systems market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.2. By Field Strength
      • 4.4.1.2.1. 1.5 Tesla (1.5T)
        • 4.4.1.2.1.1. 1.5 Tesla (1.5T) market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.2.2. 3 Tesla (3T)
        • 4.4.1.2.2.1. 3 Tesla (3T) market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.2.3. 7 Tesla (7T)
        • 4.4.1.2.3.1. 7 Tesla (7T) market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.3. By Dimensional Modality
      • 4.4.1.3.1. 3D Breast MRI
        • 4.4.1.3.1.1. 3D breast MRI market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Coils
  • 4.5.1. Coils market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.1. By Coil Configuration
      • 4.5.1.1.1. Unilateral Breast Coils
        • 4.5.1.1.1.1. Unilateral breast coils market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.1.2. Bilateral Breast Coils
        • 4.5.1.1.2.1. Bilateral breast coils market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.2. By Channel Count
      • 4.5.1.2.1. 8-Channel Breast Coils
        • 4.5.1.2.1.1. 8-channel breast coils market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.2.2. 16-Channel Breast Coils
        • 4.5.1.2.2.1. 16-channel breast coils market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.3. By Functionality
      • 4.5.1.3.1. Diagnostic-Only Coils
        • 4.5.1.3.1.1. Diagnostic-only coils market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.3.2. Biopsy-Compatible Breast Coils
        • 4.5.1.3.2.1. Biopsy-compatible breast coils market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Software
  • 4.6.1. Software market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Breast MRI Market: Imaging Technique / Contrast Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Breast MRI Market Imaging Technique / Contrast Use Movement Analysis
• 5.3. Global Breast MRI Market Size & Trend Analysis, by Imaging Technique / Contrast Use, 2021 to 2033 (USD Million)
• 5.4. Contrast-Enhanced MRI (CE-MRI)
  • 5.4.1. Contrast-Enhanced MRI (CE-MRI) market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
  • 5.5.1. Non-Contrast / Abbreviated Breast MRI (Ab-MRI) market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Breast MRI Market: Condition Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Breast MRI Market Condition Movement Analysis
• 6.3. Global Breast MRI Market Size & Trend Analysis, by Condition, 2021 to 2033 (USD Million)
• 6.4. Benign
  • 6.4.1. Benign market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.5. Malignant
  • 6.5.1. Malignant market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Breast MRI Devices: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Breast MRI Market End Use Movement Analysis
• 7.3. Global Breast MRI Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Hospitals and clinics market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.6. Breast Care Centers
  • 7.6.1. Breast care centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.7. Academic & Research Institutes
  • 7.7.1. Academic & research institutes market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. Breast MRI Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. Reimbursement scenario
    • 8.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement scenario
    • 8.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 8.5.2. India
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 8.5.4. South Korea
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement scenario
    • 8.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Global Key company market share analysis, 2024
  • 9.3.4. GE HealthCare
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Siemens Healthineers
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Philips Healthcare
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Canon Medical Systems
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Fujifilm Healthcare
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. United Imaging Healthcare
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Esaote
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. AURORA HEALTHCARE US CORP
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. QED (Quality Electrodynamics)
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. MR Instruments, Inc.
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives
  • 9.3.14. iCAD Inc.
    • 9.3.14.1. Company overview
    • 9.3.14.2. Financial performance
    • 9.3.14.3. Product benchmarking
    • 9.3.14.4. Strategic initiatives
  • 9.3.15. Subtle Medical
    • 9.3.15.1. Company overview
    • 9.3.15.2. Financial performance
    • 9.3.15.3. Product benchmarking
    • 9.3.15.4. Strategic initiatives
  • 9.3.16. Arterys (Tempus)
    • 9.3.16.1. Company overview
    • 9.3.16.2. Financial performance
    • 9.3.16.3. Product benchmarking
    • 9.3.16.4. Strategic initiatives
• 9.4. Heat Map Analysis/ Company Market Position Analysis
• 9.5. Estimated Company Market Share Analysis, 2024
• 9.6. List of Other Key Market Players